Sernova to Announce New Interim Results of its Type 1 Diabetes Clinical Trial During the 40th Annual J.P. Morgan Healthcare Conference
January 05, 2022 at 09:25 am EST
Sernova Corp. announced that new interim results from the ongoing safety, tolerability and efficacy Phase I/II clinical trial of Sernova's Cell Pouch(TM) will be released on January 10, 2022. Originally, it was planned that Dr. Piotr Witkowski, principal investigator of Sernova's Phase I/II clinical trial would present an update in a poster session at the American Society of Transplant Surgeons (ASTS) 22nd Annual "State of the Art" Winter Symposium on January 13, 2022, but the conference was postponed until the end of July 2022 because of the ongoing COVID-19 pandemic.